Study #2024-0406
Quantitative imaging biomarker prospective validation of dynamic contrast-enhanced MRI as a metric of orodental injury after radiotherapy (QI-ProVE-MRI)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This research will focus on the prospective qualification and validation of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) candidate biomarkers (i.e., Ktrans and Ve) to assess the natural history of osteoradionecrosis (ORN) and treatment for this devastating complication related to irradiation of head and neck cancers. The investigations will also include assessment of DCE-MRI candidate biomarkers for pre-qualification as quantitative imaging biomarkers of soft-tissue structures.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Orodental Injury
Study phase:
Physician name:
Stephen Lai
Department:
Head & Neck Surgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.